Hoover Institution fellow Henry Miller discusses a virulent strain of the flu this year called H3N2, as well as a need to accelerate research on the holy grail of flu prevention: a "universal" vaccine that would target a part or parts of the virus that remain unchanged among different strains, even during the virus's rapid mutations.
Ottawa, Ontario and Washington, D.C. - A group of professional ethicists and economists published an open letter urging provincial governments to reconsider proposals to ban compensation for blood plasma donations. The letter is signed by 26 ethicists and economists, including two Nobel Prize winners (Alvin Roth and Vernon Smith), a recipient of the Order of Canada (Jan Narveson), amongst others.
Tax reform legislation signed into law by President Trump in December, which will lower taxes for most Americans this year, unfortunately did nothing to stop billions of dollars in new taxes under ObamaCare from hitting millions of Americans in the wallet.
It’s hard enough for most of us to make smart long-term plans. It’s really hard for politicians to do it. So a year ago, at the beginning of our Agenda2020 series on the deep future of American health, we pulled a group of experts into a room in Washington and asked them: If we want to improve the health of a changing nation, what would you do?
Allowing U.S. consumers to engage in parallel trade would require pharmaceutical companies to lower prices here, negotiate price increases with other OECD governments, contracturally prohibit buyers from re-selling, or reduce drug sales to low-price countries so that they have no surplus to export. None of those options are as easy as lobbying the U.S. government to prevent parallel trade and preserve America's status as a lone cash cow in a world of price controls.
Dogs bark, cows moo, and regulators regulate,” former U.S. Food and Drug Administration commissioner Frank Young once quipped to explain regulatory agencies’ expansionist tendencies. There may be no better example than the FDA’s oversight of genetically engineered animals.
The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.